Recent evidence has demonstrated that CML stem/progenitor cells are able to survive independent of BCR–ABL kinase activity, suggesting that other pathways contribute to the persistence of these cells [23–25]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.